Cargando…
A Case Report of Long-Term Bisphosphonate Therapy and Atypical Stress Fracture of Bilateral Femur
Bisphosphonates are potent inhibitors of bone resorption and considered as a gold standard and are generally recommended as first-line therapy in patients with osteoporosis. Though bisphosphonates are shown to significantly reduce the risk of vertebral, non-vertebral and hip fractures, recent report...
Autores principales: | Jo, Yil Ryun, Kim, Hye Won, Moon, Seock Ho, Ko, Young Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Rehabilitation Medicine
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713302/ https://www.ncbi.nlm.nih.gov/pubmed/23869343 http://dx.doi.org/10.5535/arm.2013.37.3.430 |
Ejemplares similares
-
Bisphosphonates and Atypical Fractures of Femur
por: Yli-Kyyny, Tero
Publicado: (2011) -
Bisphosphonates and atypical subtrochanteric fractures of the femur
por: Kharwadkar, N., et al.
Publicado: (2017) -
Bilateral atypical fractures of the femur: Ten years AFTER ten years of bisphosphonate therapy
por: Smith, Matthew D., et al.
Publicado: (2021) -
Bisphosphonates and Atypical Femur Fractures: Is the Relationship Causal or Casual?
por: Bal, Rajeshwaree, et al.
Publicado: (2023) -
Surgical Fixation of Atypical Femur Fractures in Bisphosphonate-treated Patients
por: Rajput, Irfan Muhammad, et al.
Publicado: (2019)